Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History CRBP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics CRBP

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Corbus Pharmaceuticals Holding

CRBP
Current price
8.06 USD -0.42 USD (-4.95%)
Last closed 8.36 USD
ISIN US21833P3010
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 102 299 640 USD
Yield for 12 month -86.63 %
1Y
3Y
5Y
10Y
15Y
CRBP
21.11.2021 - 28.11.2021

Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, develops products to defeat serious illness. It develops CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E (MMAE), which is in Phase I clinical trial; CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells for the treatment of solid tumors; CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, including the Jenrin library of approximately 600 compounds, and multiple issued and pending patent filings. The company was incorporated in 2009 and is based in Norwood, Massachusetts. Address: 500 River Ridge Drive, Norwood, MA, United States, 02062

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

42.89 USD

P/E Ratio

Dividend Yield

Financials CRBP

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures CRBP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

-31 167 660 USD

Current Quarter

Last Quarter

EBITDA -57 240 000 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -27.18 %
PEG Ratio
Return On Equity TTM -44.89 %
Wall Street Target Price 42.89 USD
Revenue TTM
Book Value 10.39 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -100.00 %
Dividend Yield
Gross Profit TTM -42 102 000 USD
Earnings per share -4.24 USD
Diluted Eps TTM -4.24 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation CRBP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 8.26
Price Sales TTM 163.32
Enterprise Value EBITDA 0.17
Price Book MRQ 0.81

Technical Indicators CRBP

For 52 Weeks

4.64 USD 61.90 USD
50 Day MA 7.77 USD
Shares Short Prior Month 1 869 343
200 Day MA 11.24 USD
Short Ratio 14.78
Shares Short 1 542 527
Short Percent 19.03 %